Download eucalyptus - DavisPlus

Name /bks_53161_deglins_md_disk/eucalyptus
03/03/2014 09:04AM
1
Other Name(s):
Blue gum, Eucalyptus folium, Eucalyptus fructicetroum, Eucalyptus globulus,
Eucalyptus polybractea, Eucalyptus smithii, gum tree, red gum, stringy bark tree,
Tasmanium blue gum
Classification
Therapeutic: antiasthmatics, anti-infectives, expectorant
Common Uses
Topical: Rheumatic complaints, nasal congestion, mouthwash, antiseptic, dentifrice. PO: Asthma; expectorant and cough suppressant; antiseptic.
Action
The volatile oil, eucalyptol, stimulates secretion of saliva, promoting antitussive effects. It is a mild antispasmodic and antibacterial. It is a counterirritant, providing
topical analgesia. Therapeutic Effects: Relief of cough.
Pharmacokinetics
Absorption: Unknown.
Distribution: Unknown.
Metabolism and Excretion: Unknown.
Half-life: Unknown.
TIME/ACTION PROFILE
ROUTE
ONSET
PEAK
DURATION
PO, Topical
unknown
unknown
unknown
Contraindications/Precautions
Contraindicated in: Inflammation of the GI tract and bile ducts; serious liver diseases; hypotension; kidney inflammation; do not apply to face, especially the nose, of
babies and young children; Hypersensitivity.
Use Cautiously in: Pregnancy and lactation (do not use in greater amounts than
found in food); children (qsusceptibility to toxic effects of oil); Ingestion of as little
⫽ Genetic Implication.
pg 1 # 1
as 2-3 mL of essential oil may be toxic; greater amounts may be fatal. Alcohol-containing products should be used cautiously in patients with known intolerance or
liver disease; Diabetes (leaf may have hypoglycemic activity).
eucalyptus (yoo-cuh-lip-tuhs)
⫽ Canadian drug name.
Plate # 0-Composite
Adverse Reactions/Side Effects
CNS: cyanosis, delirium, drowsiness, SEIZURES (overdose). Endo: hypoglycemia.
GI: nausea, vomiting, diarrhea, epigastric pain. Resp: dyspnea, PULMONARY
EDEMA (overdose).
Interactions
Natural Product-Drug: May induce liver enzymes andpefficacy of hepatically metabolized drugs; May interfere with blood glucose control and antidiabetic drugs. Alcohol-containing preparations may interact with disulfiram and
metronidazole.
Natural-Natural Products:qtoxicity when used with other pyrrolizidine alkaloid-containing herbs, including: alkanna, borage, Crotolaria spp, gravel
root, Heliotropium spp, hemp agrimony, Henecio spp, hound’s tongue, petasites, colt’s foot, and Senecio species plants: dusty miller, alpine ragwort,
groundsel, golden ragwort, and tansy ragwort.
Route/Commonly Used Doses
PO (Adults): Asthma-200 mg of eucalyptol constituent of eucalyptus oil tid; Oil—
300– 600 mg eucalyptus oil per day and 0.05 mL– 0.2 mL per dose; leaf— steep 2 g
of leaf in 150 mL boiling water and strain. One cup of tea can be taken QD-TID; tincture (hydroalcoholic)— 3– 9 g/day.
Topical (Adults and Children): Avoid use of undiluted essential oil. Essential oil
diluted in vegetable oil is preferred (5– 20%). Apply as needed to affected area. Do
not apply to face, especially the nose, of babies and young children.
NURSING IMPLICATIONS
Assessment
● Assess frequency and nature of cough and consistency and color of sputum. Un-
less contraindicated encourage fluid intake of 1500– 2000 mL per day to decrease viscosity of secretions and facilitate expectoration.
● Monitor blood sugar in diabetics.
Potential Nursing Diagnoses
Ineffective airway clearance (Indications)
Deficient knowledge, related to medication regimen (Patient/Family Teaching)
CAPITALS indicate life-threatening, underlines indicate most frequent.
Strikethrough ⫽ Discontinued.
PDF Page #1
Name /bks_53161_deglins_md_disk/eucalyptus
03/03/2014 09:04AM
Plate # 0-Composite
pg 2 # 2
2
PDF Page #2
Implementation
● Dilute the oral and topical formulations before use.
● Do not apply the topical formulation on the face, especially the nose, in infants and
young children.
Patient/Family Teaching
● Warn patients with chronic respiratory conditions or other medical co-morbidi●
●
●
●
ties not to take this herbal supplement without the advice of their health care provider.
Caution diabetics that use of this herbal supplement may interfere with glycemic
control.
Inform patients that some formulations contain alcohol.
Instruct patients that if diarrhea, nausea, vomiting or epigastric pain develops to
stop this herbal supplement and report this to their health care provider.
Advise patient to consult health care professional if cough is unresponsive cough
or persistent cold symptoms occur.
Evaluation
● Decrease in intensity and frequency of cough.
Why was this drug prescribed for your patient?
䉷 2015 F.A. Davis Company